Regulation of stem cell-based products
van Tigerstrom, Barbara
Health Law Journal 2007; 15: 175-220
Showing items related by title, author, creator and subject.
Fink, Donald W., Jr. (2009-06-26)Cell self-renewal and the capacity to differentiate into multiple cell types (pluripotency) are biological attributes casting stem cells as attractive candidates for development of therapies targeting indications that ...
Chester, Ronald; Sackstein, Robert (2010)The breakneck speed of scientific developments in embryonic stem (ES) cell technologies is, commensurately, ushering forth new bioethical debate(s) regarding these cells. A framework of bioethical principles is presented ...
Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. Hyun, Insoo (2010-06)This paper discusses exceptional circumstances under which patients outside of clinical trials are likely to receive innovative stem cell-based interventions. These circumstances involve: (1) stem cell interventions not ...